Analysis of adverse drug reactions in 507 cases of Tislelizumab: A real-world retrospective study based on data from Guangxi, China
Saved in:
| Main Authors: | Shaohuan Lu, Dajian Chen, Yang Li, Qianxi Chen, Guangyi Meng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352749/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world study
by: Jiajin Yang, et al.
Published: (2025-04-01) -
Employing bibliometrics and natural language processing (NLP) to analyse real-world applications of adverse drug reaction
by: Viola Savy Dsouza, et al.
Published: (2025-06-01) -
Real world pharmacovigilance comparison of viloxazine and dextroamphetamine adverse reaction profiles
by: Lijun Wang, et al.
Published: (2025-08-01) -
Real-world study on adverse drug reactions of pembrolizumab in endometrial cancer treatment: insights from the FAERS database
by: Huiping Zhang, et al.
Published: (2025-08-01) -
Adverse drug events of immune checkpoint inhibitors - a retrospective, descriptive real-world data analysis
by: Lauris Annatha Mariam Auch, et al.
Published: (2025-08-01)